Taylor, J L; Unverrich, D; O'Brien, W J et al. (2000) Interferon coordinately inhibits the disruption of PML-positive ND10 and immediate-early gene expression by herpes simplex virus. J Interferon Cytokine Res 20:805-15
|
O'Brien, W J; Narasimhan, J; Guy, J et al. (1998) The effects of interferon-alpha and acyclovir on herpes simplex virus type-1 ribonucleotide reductase. Antiviral Res 38:107-16
|
Taylor, J L; Grossberg, S E (1998) The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol 25:23-9
|
Taylor, J L; Witt, P L; Irizarry, A et al. (1995) 2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells. J Interferon Cytokine Res 15:27-30
|
Taylor, J L; Tom, P; Guy, J et al. (1994) Regulation of herpes simplex virus thymidine kinase in cells treated with a synergistic antiviral combination of alpha interferon and acyclovir. Antimicrob Agents Chemother 38:853-6
|
Taylor, J L; Punda-Polic, V; O'Brien, W J (1991) Combined anti-herpes virus activity of nucleoside analogs and interferon. Curr Eye Res 10 Suppl:205-11
|
Hendricks, R L; Weber, P C; Taylor, J L et al. (1991) Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J Gen Virol 72 ( Pt 7):1601-10
|
O'Brien, W J; Coe, E C; Taylor, J L (1990) Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity. Antimicrob Agents Chemother 34:1178-82
|
Taylor, J L; Grossberg, S E (1990) Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention. Virus Res 15:1-25
|
Taylor, J L; Casey, M S; O'Brien, W J (1989) Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells. Invest Ophthalmol Vis Sci 30:365-70
|
Showing the most recent 10 out of 11 publications